Use of colistin in adult patients: A cross-sectional study-Reference-Cited by-同舟云学术

Use of colistin in adult patients: A cross-sectional study

Published:2020-03 Issue: Volume:20 Page:43-49
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Giacobbe Daniele Roberto^ORCID,Saffioti Carolina,Losito Angela Raffaella^ORCID,Rinaldi Matteo^ORCID,Aurilio Caterina^ORCID,Bolla Cesare,Boni Silvia,Borgia Guglielmo,Carannante Novella,Cassola Giovanni,Ceccarelli Giancarlo^ORCID,Corcione Silvia,Dalla Gasperina Daniela^ORCID,De Rosa Francesco Giuseppe,Dentone Chiara,Di Bella Stefano^ORCID,Di Lauria Nicoletta,Feasi Marcello,Fiore Marco^ORCID,Fossati Sara,Franceschini Erica^ORCID,Gori Andrea,Granata Guido,Grignolo Sara,Grossi Paolo Antonio,Guadagnino Giuliana,Lagi Filippo^ORCID,Maraolo Alberto Enrico^ORCID,Marinò Valeria,Mazzitelli Maria^ORCID,Mularoni Alessandra^ORCID,Oliva Alessandra,Pace Maria Caterina,Parisini Andrea,Patti Francesca,Petrosillo Nicola,Pota Vincenzo,Raffaelli Francesca,Rossi Marianna,Santoro Antonella,Tascini Carlo,Torti Carlo,Trecarichi Enrico Maria,Venditti Mario,Viale Pierluigi,Signori Alessio,Bassetti Matteo,Del Bono Valerio,Giannella Maddalena,Mikulska Malgorzata,Tumbarello Mario,Viscoli Claudio

Funder

Società Italiana di Terapia Antinfettiva

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference20 articles.

1. Management of KPC-producing Klebsiella pneumoniae infections;Bassetti;Clin Microbiol Infect,2018

2. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial;Paul;Lancet Infect Dis,2018

3. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis;Zusman;J Antimicrob Chemother,2017

4. Ceftolozane/tazobactam: place in therapy;Giacobbe;Expert Rev Anti Infect Ther,2018

5. Ceftazidime/avibactam, meropenem/vaborbactam or both? Clinical and formulary considerations;Pogue;Clin Infect Dis,2019

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tackling the outer membrane: facilitating compound entry into Gram-negative bacterial pathogens;npj Antimicrobials and Resistance;2023-12-20

2. An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options;Expert Review of Anti-infective Therapy;2023-10-09

3. Acinetobacter baumannii in the critically ill: complex infections get complicated;Frontiers in Microbiology;2023-06-22

4. Microbiologic Cure with a Simplified Dosage of Intravenous Colistin in Adults: A Retrospective Cohort Study;Infection and Drug Resistance;2023-06

5. Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit;World Journal of Clinical Cases;2023-05-06